Tag: Bolden Therapeutics Inc.
R.I.: Small state, big impact
It is easy to see why Glenn Robertelli is bullish on Rhode Island life sciences. In 2023, the sector employed more than 6,000 Rhode...
Panel: R.I. biotech sector has catching up to do
Like most leading voices in Rhode Island’s emerging life sciences sector, Neil D. Steinberg doesn’t try to deceive himself on Rhode Island’s standing in...
R.I. biotech company secures $1.5M in funding for Alzheimer’s research
PROVIDENCE – A Rhode Island-based biotech company received $1.5 million in pre-seed funding to advance its research in treating Alzheimer’s disease.
The financing, led by...












